NICE stays in the news as UK health tech rulings shape therapy access and pricing. Public body under DHSC, guides England on value, drugs, care.
The UK and US have finalized a medicines partnership allowing British drug exports to avoid US tariffs and increasing NHS drug spending. Critics warn it risks NHS funding and transparency, while supporters highlight potential benefits for patients and the UK economy. The deal's details remain partly secret, raising concerns about oversight.
Benjamin Netanyahu has disclosed that a tiny, early-stage malignant tumor was found during routine monitoring after his 2024 prostate surgery and has been treated with targeted radiation. Doctors at Hadassah Medical Center have reported that follow-up imaging and blood tests show the disease has disappeared; Netanyahu says he delayed publishing his annual medical report to avoid fuelling Iranian misinformation during current hostilities.